Practical Challenges and Translational Issues in Pharmacogenomics and Personalized Medicine from 2010 Onwards

Conclusion: Costs in the drug discovery process and the implementation of personalized medical approaches are the main barriers to the translation of pharmacogenomics from laboratory to clinic. The lack of a unified system as well as the requirement for expert analysis of data is additional barriers.
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research